<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//FR">
<HTML>
<HEAD>
 <LINK HRef="../CSS/ggrcm.css"   Rel="stylesheet" Type="text/css">
 <META name="description" content="M&eacute;dicaments &agrave; base de leuproreline acetaat">
 <META name="keywords" content="Centre Belge d'Information Pharmacoth&eacute;rapeutique; leuproreline acetaat">
 <TITLE>M&eacute;dicaments &agrave; base de Lidoca&iuml;ne</TITLE>
</HEAD>

<BODY bgcolor="#FFFFFF" LeftMargin="0" RightMargin="0" TopMargin="0" BottomMargin="0" MarginWidth="0" MarginHeight="0">
  <A Name="TopOfPage"></A>

  <TABLE Width="100%" Border="0" CellPadding="0" CellSpacing="0">
   <TR> 
    <TD Width="10">&nbsp;</TD>
    <TD Width="30%"><A HRef="../HeaderTxt/LeCBIP.htm">Le C.B.I.P.</A></TD>
    <TD Width="30%"><A HRef="../HeaderTxt/NousContacter.htm">Nous contacter</A></TD>
    <TD Width="30%"><A HRef="../HeaderTxt/Liens.htm">Sites Int&eacute;ressantes</A></TD>
   </TR> 
   <TR> 
    <TD Width="10">&nbsp;</TD>
    <TD Width="30%" Class="footer">Bon &agrave; savoir</TD>
    <TD Width="30%"><A HRef="../Index.htm"><B>Le R&eacute;pertoire</B></A></TD>
    <TD Width="30%" Class="footer">Folia</TD>
   </TR> 
   <TR> 
    <TD ColSpan="4"><HR></TD>
   </TR> 
  </TABLE> 


  <TABLE Width="100%" Border="0" CellPadding="0" CellSpacing="10">
   <TR>
    <TD>
     <H1>M&eacute;dicaments &agrave; base de <FONT Color="red">Lidoca&iuml;ne</FONT></H1>
     <TABLE Width="100%" Border="0" CellPadding="5" CellSpacing="10">
      <TR>
       <TD vAlign="top" Width="33%">
         <P><FONT CLASS="Text">1. Syst&egrave;me cardio-vasculaire<BR>1.8. Antiarythmiques<BR>1.8.2. Antiarythmiques dans les arythmies ventriculaires<BR></FONT><A Class="HYR_INMP"  HREF="../MPG/MPG_AHB.htm">1.8.2.1. Lidoca&iuml;ne</A><BR>
         <A Class="MP_INMP"  HREF="../MPG/MPG_AHB.htm#MP_00027">-Xylocard</A> [<FONT class="footer">lidoca&iuml;ne chlorhydrate</FONT>]<BR>
         <P><FONT CLASS="Text">3. Syst&egrave;me gastro-intestinal<BR>3.1. Pathologie gastrique et duod&eacute;nale<BR>3.1.2. Antiacides<BR></FONT><A Class="HYR_INMP"  HREF="../MPG/MPG_CAB.htm">3.1.2.1. *</A><BR>
         <A Class="MP_INMP"  HREF="../MPG/MPG_CAB.htm#MP_00437">-Syngel</A> [<FONT class="footer">lidoca&iuml;ne chlorhydrate</FONT>]<BR>
         <P><FONT CLASS="Text">3. Syst&egrave;me gastro-intestinal<BR>3.8. Pathologie anale<BR>3.8.1. M&eacute;dicaments contre les h&eacute;morro&iuml;des<BR></FONT><A Class="HYR_INMP"  HREF="../MPG/MPG_CHA.htm">3.8.1.1. Pr&eacute;parations sans corticost&eacute;ro&iuml;des</A><BR>
         <A Class="MP_INMP"  HREF="../MPG/MPG_CHA.htm#MP_00568">-Anusol</A> [<FONT class="footer">lidoca&iuml;ne chlorhydrate</FONT>]<BR>
         <P><FONT CLASS="Text">3. Syst&egrave;me gastro-intestinal<BR>3.8. Pathologie anale<BR>3.8.1. M&eacute;dicaments contre les h&eacute;morro&iuml;des<BR></FONT><A Class="HYR_INMP"  HREF="../MPG/MPG_CHA.htm">3.8.1.2. Pr&eacute;parations avec corticost&eacute;ro&iuml;des</A><BR>
         <A Class="MP_INMP"  HREF="../MPG/MPG_CHA.htm#MP_00573">-Hemosedan</A> [<FONT class="footer">lidoca&iuml;ne chlorhydrate</FONT>]<BR>
         <A Class="MP_INMP" HREF="../MPG/MPG_CHA.htm#MP_00576">-TriAnal</A> [<FONT class="footer">lidoca&iuml;ne chlorhydrate</FONT>]<BR>
         <A Class="MP_INMP" HREF="../MPG/MPG_CHA.htm#MP_04852">-Doloproct</A> [<FONT class="footer">lidoca&iuml;ne chlorhydrate</FONT>]<BR>
         <P><FONT CLASS="Text">5. Syst&egrave;me hormonal<BR>5.4. Corticost&eacute;ro&iuml;des<BR>5.4.6. M&eacute;thylprednisolone<BR></FONT><A Class="HYR_INMP"  HREF="../MPG/MPG_EDF.htm">5.4.6.1. *</A><BR>
         <A Class="MP_INMP"  HREF="../MPG/MPG_EDF.htm#MP_01295">-Depo-Medrol + Lidocaine</A> [<FONT class="footer">lidoca&iuml;ne chlorhydrate</FONT>]<BR>
         <P><FONT CLASS="Text">9. Pathologies ost&eacute;o-articulaires<BR>9.1. Anti-inflammatoires non st&eacute;ro&iuml;diens<BR>9.1.2. Anti-inflammatoires &agrave; usage local<BR>9.1.2.2. Autres pr&eacute;parations anti-inflammatoires &agrave; usage local<BR></FONT><A Class="HYR_INMP"  HREF="../MPG/MPG_IABB.htm">9.1.2.2.1. *</A><BR>
         <A Class="MP_INMP"  HREF="../MPG/MPG_IABB.htm#MP_02121">-Emerxil</A> [<FONT class="footer">lidoca&iuml;ne chlorhydrate</FONT>]<BR>
         <P><FONT CLASS="Text">11. Infections<BR>11.1. Antibact&eacute;riens<BR>11.1.1. Antibiotiques b&ecirc;ta-lactames<BR>11.1.1.2. C&eacute;phalosporines<BR>11.1.1.2.1. Premier groupe<BR></FONT><A Class="HYR_INMP"  HREF="../MPG/MPG_KAABA.htm">11.1.1.2.1.3. C&eacute;fazoline</A><BR>
         <A Class="MP_INMP"  HREF="../MPG/MPG_KAABA.htm#MP_05170">-Kefzol</A> [<FONT class="footer">lidoca&iuml;ne chlorhydrate</FONT>]<BR>
         <P><FONT CLASS="Text">15. Dermatologie<BR>15.4. M&eacute;dicaments des traumatismes et des affections veineuses<BR></FONT><A Class="HYR_INMP"  HREF="../MPG/MPG_OD.htm">15.4.1. *</A><BR>
         <A Class="MP_INMP"  HREF="../MPG/MPG_OD.htm#MP_02630">-Biogaze Spray</A> [<FONT class="footer">lidoca&iuml;ne chlorhydrate</FONT>]<BR>
         <P><FONT CLASS="Text">17. Oto-Rhino-Laryngologie<BR>17.1. M&eacute;dicaments &agrave; usage otique<BR>17.1.3. Anesth&eacute;siques locaux<BR></FONT><A Class="HYR_INMP"  HREF="../MPG/MPG_QAC.htm">17.1.3.1. *</A><BR>
         <A Class="MP_INMP"  HREF="../MPG/MPG_QAC.htm#MP_02359">-Otocalmine</A> [<FONT class="footer">lidoca&iuml;ne chlorhydrate</FONT>]<BR>
         <A Class="MP_INMP" HREF="../MPG/MPG_QAC.htm#MP_04120">-Otipax</A> [<FONT class="footer">lidoca&iuml;ne chlorhydrate</FONT>]<BR>
         <A Class="MP_INMP" HREF="../MPG/MPG_QAC.htm#MP_04858">-Otalgan</A> [<FONT class="footer">lidoca&iuml;ne chlorhydrate</FONT>]<BR>
         <P><FONT CLASS="Text">17. Oto-Rhino-Laryngologie<BR>17.1. M&eacute;dicaments &agrave; usage otique<BR>17.1.4. Associations<BR></FONT><A Class="HYR_INMP"  HREF="../MPG/MPG_QAD.htm">17.1.4.1. *</A><BR>
         <A Class="MP_INMP"  HREF="../MPG/MPG_QAD.htm#MP_02353">-Panotile</A> [<FONT class="footer">lidoca&iuml;ne chlorhydrate</FONT>]<BR>
         <P><FONT CLASS="Text">17. Oto-Rhino-Laryngologie<BR>17.4. Affections oro-pharyng&eacute;es<BR>17.4.1. Comprim&eacute;s &agrave; sucer<BR></FONT><A Class="HYR_INMP"  HREF="../MPG/MPG_QDA.htm">17.4.1.1. *</A><BR>
         <A Class="MP_INMP"  HREF="../MPG/MPG_QDA.htm#MP_02362">-Lemocin</A> [<FONT class="footer">lidoca&iuml;ne</FONT>]<BR>
         <A Class="MP_INMP" HREF="../MPG/MPG_QDA.htm#MP_02366">-Tyrothricine-Lidocaine</A> [<FONT class="footer">lidoca&iuml;ne chlorhydrate</FONT>]<BR>
         <A Class="MP_INMP" HREF="../MPG/MPG_QDA.htm#MP_02369">-Angin-San</A> [<FONT class="footer">lidoca&iuml;ne chlorhydrate</FONT>]<BR>
         <A Class="MP_INMP" HREF="../MPG/MPG_QDA.htm#MP_02370">-Angiocine</A> [<FONT class="footer">lidoca&iuml;ne chlorhydrate</FONT>]<BR>
         <A Class="MP_INMP" HREF="../MPG/MPG_QDA.htm#MP_02376">-Medica</A> [<FONT class="footer">lidoca&iuml;ne chlorhydrate</FONT>]<BR>
         <A Class="MP_INMP" HREF="../MPG/MPG_QDA.htm#MP_02381">-Orofar Lidocaine</A> [<FONT class="footer">lidoca&iuml;ne chlorhydrate</FONT>]<BR>
         <A Class="MP_INMP" HREF="../MPG/MPG_QDA.htm#MP_02382">-Oro Rhinathiol</A> [<FONT class="footer">lidoca&iuml;ne chlorhydrate</FONT>]<BR>
         <A Class="MP_INMP" HREF="../MPG/MPG_QDA.htm#MP_02387">-Strepsils + Lidocaine</A> [<FONT class="footer">lidoca&iuml;ne chlorhydrate</FONT>]<BR>
         <A Class="MP_INMP" HREF="../MPG/MPG_QDA.htm#MP_05201">-Golaseptine-Lidocaine</A> [<FONT class="footer">lidoca&iuml;ne chlorhydrate</FONT>]<BR>
         <P><FONT CLASS="Text">17. Oto-Rhino-Laryngologie<BR>17.4. Affections oro-pharyng&eacute;es<BR>17.4.2. Divers<BR></FONT><A Class="HYR_INMP"  HREF="../MPG/MPG_QDB.htm">17.4.2.1. *</A><BR>
         <A Class="MP_INMP"  HREF="../MPG/MPG_QDB.htm#MP_02393">-Anginol-Lidocaine</A> [<FONT class="footer">lidoca&iuml;ne chlorhydrate</FONT>]<BR>
         <A Class="MP_INMP" HREF="../MPG/MPG_QDB.htm#MP_02397">-Colludol</A> [<FONT class="footer">lidoca&iuml;ne chlorhydrate</FONT>]<BR>
         <A Class="MP_INMP" HREF="../MPG/MPG_QDB.htm#MP_02406">-Medica</A> [<FONT class="footer">lidoca&iuml;ne chlorhydrate</FONT>]<BR>
         <A Class="MP_INMP" HREF="../MPG/MPG_QDB.htm#MP_02411">-Strepsils + Lidocaine</A> [<FONT class="footer">lidoca&iuml;ne</FONT>]<BR>
         <P><FONT CLASS="Text">18. Anesth&eacute;sie<BR>18.2. Anesth&eacute;sie locale<BR></FONT><A Class="HYR_INMP"  HREF="../MPG/MPG_RB.htm">18.2.1. Anesth&eacute;siques locaux au niveau de la peau et des muqueuses</A><BR>
         <A Class="MP_INMP"  HREF="../MPG/MPG_RB.htm#MP_02092">-Emla</A> [<FONT class="footer">lidoca&iuml;ne</FONT>]<BR>
         <A Class="MP_INMP" HREF="../MPG/MPG_RB.htm#MP_02093">-Xylocaine</A> [<FONT class="footer">lidoca&iuml;ne</FONT>]<BR>
         <A Class="MP_INMP" HREF="../MPG/MPG_RB.htm#MP_04103">-Versatis</A> [<FONT class="footer">lidoca&iuml;ne</FONT>]<BR>
         <A Class="MP_INMP" HREF="../MPG/MPG_RB.htm#MP_04997">-Rapydan</A> [<FONT class="footer">lidoca&iuml;ne</FONT>]<BR>
         <A Class="MP_INMP" HREF="../MPG/MPG_RB.htm#MP_05803">-Pliaglis</A> [<FONT class="footer">lidoca&iuml;ne</FONT>]<BR>
         <P><FONT CLASS="Text">18. Anesth&eacute;sie<BR>18.2. Anesth&eacute;sie locale<BR></FONT><A Class="HYR_INMP"  HREF="../MPG/MPG_RB.htm">18.2.2. Anesth&eacute;siques locaux au niveau de l'ur&egrave;tre</A><BR>
         <A Class="MP_INMP"  HREF="../MPG/MPG_RB.htm#MP_00600">-Instillagel</A> [<FONT class="footer">lidoca&iuml;ne chlorhydrate</FONT>]<BR>
         <A Class="MP_INMP" HREF="../MPG/MPG_RB.htm#MP_05382">-Xylocaine</A> [<FONT class="footer">lidoca&iuml;ne chlorhydrate</FONT>]<BR>
       </TD>
       <TD vAlign="top" Width="33%">
         <A Class="MP_INMP" HREF="../MPG/MPG_RB.htm#MP_05939">-Cathejell</A> [<FONT class="footer">lidoca&iuml;ne chlorhydrate</FONT>]<BR>
         <P><FONT CLASS="Text">18. Anesth&eacute;sie<BR>18.2. Anesth&eacute;sie locale<BR></FONT><A Class="HYR_INMP"  HREF="../MPG/MPG_RB.htm">18.2.3. Anesth&eacute;siques locaux injectables</A><BR>
         <A Class="MP_INMP"  HREF="../MPG/MPG_RB.htm#MP_02446">-Xylocaine</A> [<FONT class="footer">lidoca&iuml;ne chlorhydrate</FONT>]<BR>
         <A Class="MP_INMP" HREF="../MPG/MPG_RB.htm#MP_02447">-Xylocaine 1% avec Adrenaline</A> [<FONT class="footer">lidoca&iuml;ne chlorhydrate</FONT>]<BR>
         <A Class="MP_INMP" HREF="../MPG/MPG_RB.htm#MP_02448">-Xylocaine 2% avec Adrenaline</A> [<FONT class="footer">lidoca&iuml;ne chlorhydrate</FONT>]<BR>
         <A Class="MP_INMP" HREF="../MPG/MPG_RB.htm#MP_06037">-Linisol</A> [<FONT class="footer">lidoca&iuml;ne chlorhydrate</FONT>]<BR>
         <P><FONT CLASS="Text">18. Anesth&eacute;sie<BR>18.2. Anesth&eacute;sie locale<BR></FONT><A Class="HYR_INMP"  HREF="../MPG/MPG_RB.htm">18.2.4. Anesth&eacute;siques locaux au niveau des muqueuses pour usage exclusif en denti</A><BR>
         <A Class="MP_INMP"  HREF="../MPG/MPG_RB.htm#MP_06039">-Oraqix</A> [<FONT class="footer">lidoca&iuml;ne</FONT>]<BR>
         <A Class="MP_INMP" HREF="../MPG/MPG_RB.htm#MP_06040">-Xogel</A> [<FONT class="footer">lidoca&iuml;ne</FONT>]<BR>
         <A Class="MP_INMP" HREF="../MPG/MPG_RB.htm#MP_06041">-Xylonor Pellets</A> [<FONT class="footer">lidoca&iuml;ne</FONT>]<BR>
         <A Class="MP_INMP" HREF="../MPG/MPG_RB.htm#MP_06042">-Xylonor Spray</A> [<FONT class="footer">lidoca&iuml;ne</FONT>]<BR>
         <P><FONT CLASS="Text">18. Anesth&eacute;sie<BR>18.2. Anesth&eacute;sie locale<BR></FONT><A Class="HYR_INMP"  HREF="../MPG/MPG_RB.htm">18.2.5. Anesth&eacute;siques locaux injectables pour usage exclusif en dentisterie</A><BR>
         <A Class="MP_INMP"  HREF="../MPG/MPG_RB.htm#MP_06043">-Lignospan</A> [<FONT class="footer">lidoca&iuml;ne chlorhydrate</FONT>]<BR>
       </TD>
      </TR>
     </TABLE>
<P Class="datum">
 <A Href="#TopOfPage">
 <IMG SRC="../Images/TopOfPage.gif" Width="18" Height="10" Border="0" onmouseover="return escape('Haut de page')"></A>&nbsp;
</P>

    </TD>
   </TR>
  </TABLE>
 <TABLE Width="100%" Border="0" CellPadding="0" CellSpacing="10">
  <TR>
   <TD Align="center">
    <HR WIDTH="90%" SIZE="1" COLOR="#008000" NOSHADE>
    <SPAN Class="footer">
 Centre Belge d 'Information Pharmacoth&eacute;rapeutique (C.B.I.P. asbl) <BR>
 c/o Heymans Instituut, De Pintelaan 185, 9000 Gent<BR>
 </SPAN>
 <A HRef="" Target="_top" Class="footer_link"><font color="#0000FF"></font></A> -
 <A HRef="mailto:redaction@cbip.be" Class="footer_link"><font color="#0000FF">redaction@cbip.be</font></A>
 - <A HRef="../Headertxt/Avertissement.htm" target="_blank" class="footer_link"><FONT Color="#0000FF">Avertissement / Disclaimer</FONT></A>
   </TD>
  </TR>
 </TABLE>

<script language="JavaScript" type="text/javascript" SRC="../JS/wz_tooltip.js"></script>
</BODY>
</HTML>
